A novel in vivo role for osteoprotegerin ligand in activation of monocyte effector function and inflammatory response (Q46743257)

24 December 2017

title

A novel in vivo role for osteoprotegerin ligand in activation of monocyte effector function and inflammatory response (English)

1 reference

24 December 2017

0 references

8

Iqbal S Grewal

1 reference

24 December 2017

author name string

Dhaya Seshasayee

1

1 reference

24 December 2017

Hua Wang

2

1 reference

24 December 2017

Wyne P Lee

3

1 reference

24 December 2017

Peter Gribling

4

1 reference

24 December 2017

Jed Ross

5

1 reference

24 December 2017

Nicholas Van Bruggen

6

1 reference

24 December 2017

Richard Carano

7

1 reference

24 December 2017

language of work or name

English

0 references

publication date

15 May 2004

1 reference

24 December 2017

Journal of Biological Chemistry

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

24 December 2017

volume

279

1 reference

24 December 2017

issue

29

1 reference

24 December 2017

page(s)

30202-30209

1 reference

24 December 2017

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

The TNF and TNF receptor superfamilies: integrating mammalian biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

Development and maturation of secondary lymphoid tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

RANK is essential for osteoclast and lymph node development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

RANKing the importance of measles virus in Paget's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

Mitogen-activated protein kinases: specific messages from ubiquitous messengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

CD40 signaling of monocyte inflammatory cytokine synthesis through an ERK1/2-dependent pathway. A target of interleukin (il)-4 and il-10 anti-inflammatory action

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

The proto-oncogene Bcl-2 and its role in regulating apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

Apoptosis in human autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

The many roles of CD40 in cell-mediated inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403968200

21 January 2018

Identifiers

DOI

10.1074/JBC.M403968200

1 reference

24 December 2017

1 reference

24 December 2017